er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
Reprint version of article Features associated with the article       Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
Accession information: Vol. 6; Issue 13; 2 July 2004
PDF

Primary T-cell immunodeficiencies

Waseem Qasim, H. Bobby Gaspar and Adrian J. Thrasher

Author contact details

Table 1. Primary T-cell immunodeficienciesa
Disorder Chromosomal localisation Mutated geneb Molecular defect Immuno-phenotype

Refs

SCID-X1 Xq13 Common g-chain Absence of receptors for IL-2, -4, -7, -9, -15 and -21 T-B+NK- 5, 6
JAK3 deficiency 19p13 JAK3 Defect of signalling via IL-2, -4, -7, -9, -15 and -21 T-B+NK- 54
IL-7 receptor deficiency 5p13 IL-7 receptor a Absence of IL-7 receptor a T-B+NK+ 55
RAG-1 and -2 deficiency 11p13 RAG-1 and RAG-2 Defective VDJ recombination T-B-NK+ 12
Artemis deficiency 10p13 Artemis

Defective VDJ recombination; radiation sensitivity

T-B-NK+ 13

Adenosine deaminase deficiency

20q12-13 ADA Block in purine salvage metabolism T-B-NK+/- 9, 10

Purine nucleoside phosphorylase deficiency

14q11 PNP Block in purine salvage metabolism T-B-NK+/- 56

T-cell receptor deficiencies

11q23 CD3 g/d/e Defective T-cell signalling T+/-B+NK+ 57, 58, 59
CD45 deficiency 1q31-32 CD45 Defective T- and B-cell signalling T-B+NK- 60

a Adapted from Ref. 2, with permission from the BMJ Publishing Group.
b Gene products are listed.
Abbreviations: ADA, adenosine deaminase; B, B cell; IL, interleukin; JAK, Janus kinase; NK, natural killer cell; PNP, purine nucleoside phosphorylase; RAG, recombination-activating gene; SCID, severe combined immunodeficiency; T, T cell.


References cited in Table 1

5 Puck, J.M. et al. (1993) The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2, 1099-1104, PubMed

6 Noguchi, M. et al. (1993) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-157, PubMed

9 Giblett, E.R. et al. (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2, 1067-1069, PubMed

10 Valerio, D. et al. (1984) Cloning of human adenosine deaminase cDNA and expression in mouse cells. Gene 31, 147-153, PubMed

12 Schwarz, K. et al. (1996) RAG mutations in human B cell-negative SCID. Science 274, 97-99, PubMed

13 Moshous, D. et al. (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177-186, PubMed

54 Russell, S.M. et al. (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800, PubMed

55 Puel, A. et al. (1998) Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 20, 394-397, PubMed

56 Williams, S.R. et al. (1987) A human purine nucleoside phosphorylase deficiency caused by a single base change. J Biol Chem 262, 2332-2338, PubMed

57 Arnaiz-Villena, A. et al. (1992) Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor. N Engl J Med 327, 529-533, PubMed

58 Dadi, H.K., Simon, A.J. and Roifman, C.M. (2003) Effect of CD3delta deficiency on maturation of alpha/beta and gamma/delta T-cell lineages in severe combined immunodeficiency. N Engl J Med 349, 1821-1828, PubMed

59 Soudais, C. et al. (1993) Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat Genet 3, 77-81, PubMed

60 Kung, C. et al. (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 6, 343-345, PubMed

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk